GLP-1 Medications and Fertility: What We Know

Reading Time: 2 minutes

Key Takeaways

  • GLP-1 medications can improve metabolic health, which may indirectly support fertility in some patients.
  • These medications should not be used during pregnancy.
  • Most patients should stop GLP-1 medications at least two months before trying to conceive.
  • GLP-1 medications are not fertility treatments and should be coordinated carefully with fertility care.
  • A personalized plan with a fertility specialist is essential.

Medications like Ozempic®, Wegovy®, and Mounjaro® have become widely known for their effectiveness in weight management and metabolic health. These medications classified as GLP-1 receptor agonists are increasingly used by individuals who are also thinking about future fertility, egg freezing, or pregnancy.

As interest grows, so do questions:
Can GLP-1 medications affect fertility? Should you stop them before trying to conceive? Do they impact IVF outcomes?

Here’s what current medical evidence and fertility specialists know so far.

What Are GLP-1 Medications?

GLP-1 (glucagon-like peptide-1) receptor agonists are medications originally developed to treat type 2 diabetes and later approved for chronic weight management. They work by:

  • Improving insulin sensitivity
  • Reducing appetite and slowing gastric emptying
  • Supporting weight loss and metabolic health

Common examples include semaglutide and tirzepatide-based medications.

How GLP-1 Medications May Impact Fertility

1. Weight and Hormonal Balance

For individuals with obesity or insulin resistance, weight loss can improve ovulation, menstrual regularity, and overall reproductive health. In these cases, GLP-1 medications may indirectly support fertility by improving metabolic function.

This is especially relevant for patients with conditions like:

2. Ovulation and Menstrual Cycles

Some patients experience more regular cycles as weight and insulin resistance improve. However, GLP-1 medications themselves do not stimulate ovulation and are not fertility treatments.

Importantly, rapid weight loss or nutritional deficiencies can temporarily disrupt cycles in some individuals highlighting the importance of medical supervision.

3. Pregnancy Safety and Why Timing Matters

GLP-1 medications are not recommended during pregnancy. Animal studies have shown potential risks to fetal development, and there is currently limited human data.

Most medical guidelines recommend discontinuing GLP-1 medications at least 2 months before attempting conception, allowing the medication to fully clear the body.

If pregnancy occurs while taking a GLP-1 medication, patients should contact their healthcare provider immediately.

GLP-1 Medications and IVF or Egg Freezing

For patients pursuing fertility treatment, timing and coordination are key.

  • GLP-1 medications may be used before treatment to optimize weight and metabolic health.
  • They are typically stopped prior to IVF cycles, egg freezing, or embryo transfer.
  • There is no strong evidence that GLP-1 medications improve IVF success rates directly—but overall health optimization can be beneficial.

Each treatment plan should be individualized based on medical history, goals, and fertility timeline.

If you’re using or considering GLP-1 medications and thinking about fertility, egg freezing, or IVF, early conversations matter. At Reproductive Partners Fertility Center – San Diego, our physicians take a personalized, evidence-based approach to help patients navigate weight management, fertility goals, and treatment timing safely and effectively.

Let's Take the Next Step

Our skilled fertility specialists are here to help. Contact us today and let’s discuss the next phase of your fertility journey.